NARI stock forecast
Our latest prediction for Inari Medical Inc's stock price was made on the Oct. 7, 2021 when the stock price was at 80.97$.
In the short term (2weeks), NARI's stock price should underperform the market by -1.32%. During that period the price should oscillate between -7.95% and +6.89%.
In the medium term (3months), NARI's stock price should underperform the market by -2.42%. During that period the price should oscillate between -26.77% and +19.44%.Get email alerts
Create a solid portfolio with NARI
About Inari Medical Inc
Inari Medical, Inc. is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. Inari has developed two minimally-invasive, novel catheter-based mechanical thrombectomy devices that are designed to remove large clots from large vessels and eliminate the need for thrombolytic drugs. The company purpose-built its products for the specific characteristics of the venous system and the treatment of the two distinct manifestations of venous thromboembolism, or VTE: deep vein thrombosis and pulmonary embolism. The ClotTriever system is 510(k)-cleared by the FDA and CE Mark approved for the treatment of deep vein thrombosis. The FlowTriever system is 510(k)-cleared by the FDA and CE Mark approved for the treatment of pulmonary embolism and clot in transit in the right atrium.
At the moment the company generates 208M USD in revenues.
On its last earning announcement, the company reported a profit of 0.47$ per share.
The book value per share is -0.74$
Three months stock forecastOct. 7, 2021
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|